JP2020180140A5 - - Google Patents

Download PDF

Info

Publication number
JP2020180140A5
JP2020180140A5 JP2020117566A JP2020117566A JP2020180140A5 JP 2020180140 A5 JP2020180140 A5 JP 2020180140A5 JP 2020117566 A JP2020117566 A JP 2020117566A JP 2020117566 A JP2020117566 A JP 2020117566A JP 2020180140 A5 JP2020180140 A5 JP 2020180140A5
Authority
JP
Japan
Prior art keywords
formula
compound represented
alkyl
methyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020117566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020180140A (ja
JP7247144B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020180140A publication Critical patent/JP2020180140A/ja
Publication of JP2020180140A5 publication Critical patent/JP2020180140A5/ja
Priority to JP2023040667A priority Critical patent/JP7508620B2/ja
Application granted granted Critical
Publication of JP7247144B2 publication Critical patent/JP7247144B2/ja
Priority to JP2024098472A priority patent/JP2024123117A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020117566A 2018-03-20 2020-07-08 ジヒドロクロメン誘導体 Active JP7247144B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023040667A JP7508620B2 (ja) 2018-03-20 2023-03-15 ジヒドロクロメン誘導体
JP2024098472A JP2024123117A (ja) 2018-03-20 2024-06-19 ジヒドロクロメン誘導体

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018052971 2018-03-20
JP2018052971 2018-03-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020507833A Division JP6733072B2 (ja) 2018-03-20 2019-03-19 ジヒドロクロメン誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023040667A Division JP7508620B2 (ja) 2018-03-20 2023-03-15 ジヒドロクロメン誘導体

Publications (3)

Publication Number Publication Date
JP2020180140A JP2020180140A (ja) 2020-11-05
JP2020180140A5 true JP2020180140A5 (https=) 2022-06-20
JP7247144B2 JP7247144B2 (ja) 2023-03-28

Family

ID=67986459

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020507833A Active JP6733072B2 (ja) 2018-03-20 2019-03-19 ジヒドロクロメン誘導体
JP2020117566A Active JP7247144B2 (ja) 2018-03-20 2020-07-08 ジヒドロクロメン誘導体
JP2023040667A Active JP7508620B2 (ja) 2018-03-20 2023-03-15 ジヒドロクロメン誘導体
JP2024098472A Pending JP2024123117A (ja) 2018-03-20 2024-06-19 ジヒドロクロメン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020507833A Active JP6733072B2 (ja) 2018-03-20 2019-03-19 ジヒドロクロメン誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023040667A Active JP7508620B2 (ja) 2018-03-20 2023-03-15 ジヒドロクロメン誘導体
JP2024098472A Pending JP2024123117A (ja) 2018-03-20 2024-06-19 ジヒドロクロメン誘導体

Country Status (21)

Country Link
US (3) US10807993B2 (https=)
EP (1) EP3770162B1 (https=)
JP (4) JP6733072B2 (https=)
KR (1) KR102799186B1 (https=)
CN (1) CN111886237B (https=)
AU (1) AU2019239481B2 (https=)
CA (1) CA3092255A1 (https=)
CY (1) CY1126034T1 (https=)
DK (1) DK3770162T3 (https=)
EA (1) EA202092206A1 (https=)
ES (1) ES2941771T3 (https=)
FI (1) FI3770162T3 (https=)
HU (1) HUE062256T2 (https=)
MX (1) MX2020009763A (https=)
MY (1) MY202583A (https=)
PH (1) PH12020551497A1 (https=)
PL (1) PL3770162T3 (https=)
PT (1) PT3770162T (https=)
SG (1) SG11202007979UA (https=)
TW (1) TWI899051B (https=)
WO (1) WO2019181939A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3770162T3 (pl) * 2018-03-20 2023-06-05 Sumitomo Pharma Co., Ltd. Pochodne dihydrochromenu
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
WO2025100519A1 (ja) * 2023-11-09 2025-05-15 住友ファーマ株式会社 ジヒドロクロメン誘導体を含むがんの治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045707A1 (en) 1999-12-21 2001-06-28 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US20090111805A1 (en) 2005-02-24 2009-04-30 Pfizer Inc. Bicyclic heteroaromatic derivatives useful as anticancer agents
US20080255149A1 (en) * 2005-09-27 2008-10-16 Novartis Ag Carboxyamine Compounds and Methods of Use Thereof
EP1847542A1 (en) 2006-04-21 2007-10-24 Laboratorios del Dr. Esteve S.A. Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
HRP20160625T1 (hr) * 2007-09-10 2016-08-12 Boston Biomedical, Inc. Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka
RU2018101897A (ru) * 2015-06-22 2019-07-24 Сумитомо Дайниппон Фарма Ко., Лтд. Бициклическое гетероциклическое амидное производное
CA2990583A1 (en) 2015-06-22 2016-12-29 Sumitomo Dainippon Pharma Co., Ltd. 1,4-disubstituted imidazole derivative
JP6896701B2 (ja) * 2016-02-26 2021-06-30 大日本住友製薬株式会社 イミダゾリルアミド誘導体
TW201821105A (zh) * 2016-10-20 2018-06-16 美商弗瑪治療公司 使用hdac11抑制劑之方法
PL3770162T3 (pl) 2018-03-20 2023-06-05 Sumitomo Pharma Co., Ltd. Pochodne dihydrochromenu
JP2020019752A (ja) 2018-08-03 2020-02-06 大日本住友製薬株式会社 クロマン誘導体

Similar Documents

Publication Publication Date Title
JP2020180140A5 (https=)
JP2022533398A5 (https=)
JP2010505873A5 (ja) 化合物、会合複合体、及び会合複合体を形成する方法
JP2008535831A5 (https=)
JP2007530450A5 (https=)
JP2007512370A5 (https=)
JP2005529934A5 (https=)
JP2010532340A5 (https=)
JP2007513170A5 (https=)
JP2008189687A5 (https=)
JP2008538743A5 (https=)
JP2008525416A5 (https=)
ATE453645T1 (de) Verfahren zur herstellung von pyrrolotriazinverbindungen, die sich als kinaseinhibitoren eignen
JP2007517035A5 (https=)
RU2010152758A (ru) Кристаллическая форма и тозилат соединения тетрациклина, кристаллическая форма указанного тозилата и ее полиморфная модификация, способ получения тозилата соединения тетрациклина, полиморфная модификация, полученная указанным способом, и фармацевтические композиции на основе вышеуказанных кристаллической формы и полиморфной модификации
JP2009513806A5 (https=)
JP2023535409A5 (https=)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2023538524A5 (https=)
RU2014125435A (ru) Способ получения производных стерина
JP2004504323A5 (https=)
JP2008069182A5 (https=)
JP2016521277A5 (https=)
JP2009544704A5 (https=)
JP2021504302A5 (https=)